| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 2,101,884 | 2,270,187 | 2,636,313 | 2,167,120 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 2,101,884 | 2,270,187 | 2,636,313 | 2,167,120 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 353,688 | 355,648 | 440,974 | 355,899 | | Non Recurring | 46,740 | 20,678 |
-
|
-
| | Others | (86,198) | 444,773 | 1,940,322 | 190,644 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,787,654 | 1,449,088 | 255,017 | 1,620,577 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,787,654 | 1,449,088 | 255,017 | 1,620,577 | | Interest Expense | 1,365,918 | 1,615,445 | 1,976,642 | 1,879,811 | | Income Before Tax | 421,736 | (166,357) | (1,721,625) | (259,234) | | Income Tax Expense | 153,074 | (62,488) | (86,904) | 84,449 | | Minority Interest | (2,926) | 65 | (537) | (77) | | | | Net Income From Continuing Ops | 265,736 | (103,804) | (1,635,258) | (343,760) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 265,736 | (103,804) | (1,635,258) | (343,760) | | Preferred Stock And Other Adjustments | (27,391) | (29,025) | (9,622) | (9,274) | | | Net Income Applicable To Common Shares | $238,345 | ($132,829) | ($1,644,880) | ($353,034) |
|
7.87% Nasdaq 
Income Statement
